COMMONWEALTH EQUITY SERVICES, LLC - ARIDIS PHARMACEUTICALS INC ownership

ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 16 filers reported holding ARIDIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ARIDIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$142
-29.7%
646,0000.0%0.00%
Q1 2023$202
-70.2%
646,000
+12.3%
0.00%
-100.0%
Q4 2022$678
-99.9%
575,000
+1.4%
0.00%
+100.0%
Q3 2022$527,000
-15.4%
567,2000.0%0.00%
-50.0%
Q2 2022$623,000
-38.6%
567,200
-1.7%
0.00%0.0%
Q1 2022$1,015,000
+2059.6%
577,200
+2757.4%
0.00%
Q4 2021$47,00020,2000.00%
Other shareholders
ARIDIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 347,517$1,279,0001.69%
AIGH Capital Management LLC 150,591$554,0000.12%
ARMISTICE CAPITAL, LLC 1,068,444$3,932,0000.07%
PERRITT CAPITAL MANAGEMENT INC 16,000$59,0000.03%
Minot Wealth Management LLC 25,000$92,0000.02%
Wealth Architects, LLC 14,077$52,0000.01%
TCI Wealth Advisors, Inc. 100$00.00%
FMR LLC 600$2,0000.00%
WELLS FARGO & COMPANY/MN 1,271$4,0000.00%
NORTHERN TRUST CORP 16,572$61,0000.00%
View complete list of ARIDIS PHARMACEUTICALS INC shareholders